NASDAQ · Drug Manufacturers - Specialty & Generic

Aurora Cannabis Inc. (ACB) Stock

$3.88 -2.27% NASDAQ: ACB Healthcare

Valuation

MetricValue
Price$3.88
Market Cap$245.64M
P/E Ratio-2.89
P/B Ratio0.65
P/S Ratio1.19
EPS (TTM)$0.03
52-Week High$6.67
52-Week Low$2.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-21.00%
ROA-17.83%
ROCE-15.72%
Gross Margin1.46%
Operating Margin1.46%
Net Margin-38.15%
Debt/Equity0.04
Current Ratio4.33

Annual Financials (USD)

Metric20222023202420252026
Revenue$221.0M$224.0M$270.0M$343.0M$321.0M
Operating Profit$-231.0M$-207.0M$-46.0M$5.0M$-47.0M
Net Profit$-1.7B$-817.0M$-69.0M$2.0M$-122.0M
EPS$-79.92$-8.17$-1.28$0.03$-2.14
Op Margin-104.6%-92.6%-17.2%1.4%-14.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$926.0M$926.0M$840.0M$848.0M$603.0M
Total Liabilities$405.0M$405.0M$237.0M$243.0M$89.0M
Cash$301.0M$301.0M$180.0M$184.0M$113.0M
Borrowings$226.0M$226.0M$100.0M$104.0M$24.0M

Latest News

ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out? Zacks · Jul 15, 2026 Weekly Roundup on the Cannabis Sector & Psychedelic Sector Market Exclusive · Jul 13, 2026 Aurora Named to TIME Canada's Best Companies 2026 List CNW Group · Jul 9, 2026 VFF Stock Loses 27% in Three Months: Time to Invest or Exit? Zacks · Jul 8, 2026 Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders CNW Group · Jul 8, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-110.0M$-86.0M$-69.0M$16.0M$-14.0M
Investing Cash Flow$-68.0M$-27.0M$-20.0M$-33.0M$-95.0M
Financing Cash Flow$-32.0M$-4.0M$0$0$3.0M
Net Cash Flow$16.0M$-134.0M$-119.0M$2.0M$-73.0M
Free Cash Flow$-142.0M$-93.0M$-85.0M$-3.0M$-36.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA-3.73
FCF Yield-14.74%
Quick Ratio2.80
Interest Coverage-17.97
Return 1Y-41.92%
Return 3Y-50.19%
Return 5Y-96.38%

Ownership

Insiders Held1.27%
Institutions Held9.70%
Institutions Float Held9.83%
Institutional HolderSharesReport Date
Tidal Investments LLC1,249,6672026-03-31
Goldman Sachs Group Inc1,056,2182026-03-31
Renaissance Technologies, LLC758,1812026-03-31
National Bank of Canada/FI/271,2902026-03-31
Morgan Stanley259,0552026-03-31

About Aurora Cannabis Inc.

Aurora Cannabis Inc. is led by CEO Miguel Martin, employs 1,073 people, headquartered in CA, publicly traded since 2014.

Aurora Cannabis Inc. (ACB) stock trades at $3.88 with a market capitalization of $245.64M. The stock is valued at a negative price-to-earnings (P/E) ratio of -2.89, reflecting a net loss over the last twelve months, price-to-book of 0.65, price-to-sales of 1.19. Over the past 52 weeks the stock has ranged between $2.56 and $6.67, and currently trades 41.8% below its 52-week high.

On profitability, Aurora Cannabis Inc. generates a return on equity (ROE) of -21.00% (negative, reflecting a net loss), return on capital employed of -15.72%, an operating margin of 1.46%, a net profit margin of -38.15%.

Aurora Cannabis Inc. by the numbers, 2017–2026

Between 2017 and 2026 Aurora Cannabis Inc. reported revenue of $18.0M rising to $321.0M, a change of +1683.3% across 10 years. Compounded, revenue has grown 5.5% a year over five years, 12.7% over three, -6.4% over the last twelve months. Net profit fell to $-122.0M.

Operating margin went from -62.0% in 2017 to -14.6% in 2026, a gain of 47.4 percentage points. The most recent net margin is -38.15%. On a trailing twelve-month basis to Jun '26, revenue is $290.0M and net profit $-110.0M.

Borrowings fell from $64.0M to $24.0M, cash from operations was $-14.0M in the latest year, positive in 1 of the last 10.

Return on equity has averaged -111.3% over five years, and was -23.8% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Aurora Cannabis Inc. (ACB) — frequently asked questions

What is Aurora Cannabis Inc. (ACB) stock price today?

Aurora Cannabis Inc. (ACB) is currently trading at $3.88, down 2.27% today.

What is ACB P/E ratio?

Aurora Cannabis Inc.'s P/E ratio is -2.89. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ACB return on equity (ROE)?

Aurora Cannabis Inc.'s return on equity (ROE) is -21.00%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Aurora Cannabis Inc.'s market cap?

Aurora Cannabis Inc. has a market capitalization of $245.64M.

Does ACB pay a dividend?

Aurora Cannabis Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does ACB carry?

Aurora Cannabis Inc. has a debt-to-equity ratio of 0.04. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is ACB's profit margin?

Aurora Cannabis Inc. reports a net profit margin of -38.15% — the share of revenue left after every cost, including tax and interest.

What sector is ACB in?

Aurora Cannabis Inc. is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is ACB listed on?

Aurora Cannabis Inc. trades on NASDAQ under the ticker ACB.

What is ACB's 52-week range?

Over the last year Aurora Cannabis Inc. has traded between $2.56 and $6.67.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens ACB currently matches

On the figures above, Aurora Cannabis Inc. passes the filters for 6 of our ready-made screens, among them Penny Stocks, Stocks Under $5, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksStocks Under $5Stocks Under $10Debt Free Stocks Under $100Micro Cap StocksDebt Free Micro Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.